Bayesian Capital Management, LP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$2,337,365
+42.9%
147,282
+69.9%
0.27%
+51.7%
Q2 2023$1,635,689
+1919.4%
86,682
+766.8%
0.18%
+826.3%
Q1 2021$81,000
+42.1%
10,000
-19.4%
0.02%
+46.2%
Q2 2020$57,000
-59.9%
12,400
-70.1%
0.01%
-58.1%
Q1 2020$142,000
+173.1%
41,500
+117.7%
0.03%
+210.0%
Q1 2019$52,00019,0600.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders